In October 2013 the FDA approved Opsumit (Macitnentan) and Adempas (Riociguat) to treat pulmonary arterial hypertension. Adempas was the first medication approved to treat two kinds of pulmonary hypertension. It can be used to treat pulmonary arterial hypertension as well as chronic thromboembolic pulmonary hypertension. … [Read more...]
Archives for April 2014
Pregnancy and Pulmonary Hypertension Part 2
The literature has described the risk of pregnancy to the mother as very severe in patients with advanced PAH. Depending on how advanced the PAH, there may be a 50% to 80% chance of death. For patients with much milder PAH, the risks are much lower but still substantial. … [Read more...]